ALNYLAM PHARMACEUTICALS, INC.
CIK 1178670 · last filed 2016-02-24
ALNYLAM PHARMACEUTICALS, INC. is a corporate insider who has filed 20 SEC Form 4 insider transactions across 1 company since 2012. The most recent filing shows the insider sold $7.2M of RGLS on Feb 24, 2016. Across all open-market trades the lifetime net is −$11.3M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
20
-$11.28M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Regulus Therapeutics Inc. (RGLS) Delisted | 10%+ Owner | 4,896,716 | $8.16 | $39.96M | -$11.28M | 20 | 2016-02-24 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-02-24 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −1,000,000 | -$7.18M | EDGAR |
| 2014-10-28 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −113,084 | -$1.59M | EDGAR |
| 2014-10-24 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −113,084 | -$1.59M | EDGAR |
| 2014-10-17 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −12,100 | -$81.5K | EDGAR |
| 2014-10-10 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −10,050 | -$65.9K | EDGAR |
| 2014-10-03 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −10,300 | -$69.4K | EDGAR |
| 2014-09-26 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −8,750 | -$62.4K | EDGAR |
| 2014-09-19 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −7,700 | -$56.3K | EDGAR |
| 2014-09-12 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −8,900 | -$69.9K | EDGAR |
| 2014-09-05 | Regulus Therapeutics Inc. (RGLS) Delisted | Sell (S) | −10,050 | -$71.1K | EDGAR |